Breast cancer survivor Kate Dilligan is the CEO of Cooler Heads, a company that sells a portable and self-administered scalp cooling device. The system helps chemotherapy patients retain their hair, as therefore their self-esteem and privacy. The post ‘It’s Not About Beauty, It’s About Privacy’: How One Cancer Survivor Is Changing Chemo Care appeared first…
In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the company recently received through the Sprint for Women’s Health program. The post MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding appeared first on MedCity News.
Jason Farned y su equipo en el Distrito de Control de Mosquitos y Vectores del Valle de San Gabriel habían pasado años preparándose para la posible llegada del dengue, un virus peligroso que normalmente se encuentra en climas tropicales fuera de Estados Unidos continental. Habían observado con nerviosismo cómo las especies de mosquitos Aedes invasores,…
You’re pregnant, healthy, and hearing mixed messages: Health and Human Services Secretary Robert F. Kennedy Jr., who is not a scientist or doctor, says you don’t need the covid vaccine, but experts at the Centers for Disease Control and Protection still put you in a high-risk group of people who ought to receive boosters. The…
Samsung announced its plans to acquire French medtech startup Sonio. The startup’s AI platform, which was cleared by the FDA last year, automates ultrasound reporting so that healthcare providers can conduct these exams with greater accuracy and efficiency. The post Samsung Acquires AI-Powered Prenatal Ultrasound Startup appeared first on MedCity News.
Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after the same target. Biologics are a new treatment option for COPD following approvals of antibodies from Sanofi and GSK. The post Roche Reports Mixed Data…
Using the ED for non-emergencies costs more than many people’s monthly student loan payments and strains an already fragile system. Employers who bridge knowledge gaps and educate employees in engaging ways can foster a healthier workforce and reduce ED strain. The post The ER Is Bursting at the Seams — Employers Hold the Key to…
This policy watch post examines the United States’ measles elimination status, including what it means to eliminate measles, whether the current measles outbreak could threaten the country’s measles elimination status, and what losing that status might mean for measles control.
This is part 2 of Jeff Goldsmith’s history of managed care. If you missed it read Part 1 By JEFF GOLDSMITH The late 1990s crash of HMOs opened the door to a major consolidation of the health insurance market controlled largely by national and super-regional health plans. While HMOs by no means disappeared post-backlash, the…
By GEORGE HALVORSON Special Needs Plans Change Lives for The Lowest Income and Highest Need Patients The people who benefit the most from Medicare Advantage are clearly the very low-income and high health-need people who are eligible for both Medicare and Medicaid as programs and who enroll as members in the Medicare Advantage Special Needs…